|
⚲
|
| Nitric Biotherapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001460586 |
| Sale | 2009-03-31 ($2.2 M Offered, $1.7 M Sold) |
| Fund | |
| Phone | 2157886200 |
| Address | 2 Canals End Road Bristol, 19007 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Zev Scherl | |
| Richard Caruso | |
| Matthew Rieke | |
| Frank McCaney | |
| Hugh Macnaught | |
| Harold Chefitz |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Prism ER Ventures, LLC
✚
|
0.0 | |
|
Qiu Jiahao
✚
|
0.0 | |
|
Roach James M.
✚
|
0.0 | |
|
Roers Investments IX LLC
✚
|
0.0 | |
|
Ryan James P
✚
|
0.0 | |
|
Sears Roebuck & Co
✚
|
0.0 | |
|
Scharp Robert C
✚
|
0.0 | |
|
SEI Holding II LP
✚
|
0.0 | |
|
Sensoriant, Inc.
✚
|
0.0 | |
|
Podium Corporation, Inc.
✚
|
0.0 |